Darlene Colon

Director, Early & Late Phase Clinical Business Development at QPS

Darlene Colon is the current Director of Business Development for QPS MRA, LLC. Darlene has held this position for 4 years and 8 months. Prior to their current role, Darlene served as the Director of Budgets & Contracts for Advanced Pharma CR, LLC for 6 months. Darlene also served as the Director of Business Development for Elite Research Institute Inc. for 2 years and 2 months. In their previous role as an Account Manager for Radiant Research/Comprehensive Clinical Development Inc., Darlene was responsible for overseeing client requests and maintaining relationships with internal and external customers. Darlene also cultivated and managed study start- up metrics for study leads through the award process. Darlene began their career in the pharmaceutical industry as an Administrative Assistant for Kos Pharmaceuticals for 2 years before moving into a Proposal Manager/Senior Budget Analyst role at Comprehensive Clinical Development, Inc., where they worked for 5 years and 2 months. Throughout their career, Darlene has demonstrated their dedication to their work and their ability to build strong relationships with their colleagues and clients.

Darlene Colon has an MBA from American InterContinental University-South Florida and a Bachelor's from American InterContinental University-South Florida. Darlene also has an Associate's from Barton Community College.

This team is responsible for the clinical business development of both early and late phase projects. The team is led by Darlene Colon and includes Mark McDonald, Robert Barlow, Andrew Nehls, Jonathan Quinn, Edwin van Vulpen, Jim Cunningham, Jose L. Marcos, Benjamin Abrams, and Sandra Achterhof.

Links

Timeline

  • Director, Early & Late Phase Clinical Business Development

    Current role

View in org chart